Skip to content

The efficacy in adjunctive treatment and safety of Eucerin Complete Repair in the treatment of keratosis pilaris: an open-label, randomized

The efficacy in adjunctive treatment and safety of Eucerin Complete Repair in the treatment of keratosis pilaris: an open-label, randomized

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20231114008
Enrollment
24
Registered
2023-11-14
Start date
2023-05-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with keratosis pilaris on both arms keratosis pilaris

Interventions

Eucerin complete repair emollient cream with 10% lactic acid and 0.025% tretinoin,10% lactic acid and 0.025% tretinoin
Active Comparator Drug,Active Comparator Drug
Eucerin,control

Sponsors

Beiersdorf Thailand Co.,Ltd
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Healthy individuals aged 18-60 years diagnosed with keratosis pilaris and symmetric keratosis pilaris on both arms of any severity were inclusion criteria of the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria included a history of vitamin A analog, alpha-hydroxy acid, beta-hydroxy acid, or urea use within the past four months. In addition, the study did not include individuals with a history of esthetic procedures (e.g., chemical peels, laser treatments) on the surface of both arms, other skin conditions affecting both arms, and individuals who were currently pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
Skin texture 0 2 4 8 weeks Antera3D,Skin hydration 0 2 4 8 weeks corneometer,Transepidermal water loss 0 2 4 8 weeks tewameter,Clinical improvement 0 2 4 8 weeks Investigator assessment

Secondary

MeasureTime frame
Melanin 0 2 4 8 weeks Antera 3D,Erythema 0 2 4 8 weeks Antera3D

Countries

Thailand

Contacts

Public ContactRatchathorn Panchaprateep

Faculty of Medicine, Chulalongkorn University

rpanchaprateep@gmail.com0898923819

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026